APP and Alzheimer disease: As we expected, astroglial activation enhanced in AD advance stages can be observed in 12-month-old APP/PS1 mice by the presence of abundant GFAP-positive astrocytes in their cerebral cortex compared to aged-matched control mice (Figure 4D).